• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种化学稳定的胰高血糖素类似物,可立即用于治疗危及生命的低血糖。

A glucagon analog chemically stabilized for immediate treatment of life-threatening hypoglycemia.

机构信息

Indiana University, Department of Chemistry, Bloomington, IN 47405, USA.

出版信息

Mol Metab. 2014 Jan 22;3(3):293-300. doi: 10.1016/j.molmet.2014.01.006. eCollection 2014 Jun.

DOI:10.1016/j.molmet.2014.01.006
PMID:24749059
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3986664/
Abstract

For more than half a century glucagon has been used as a critical care medicine in the treatment of life-threatening hypoglycemia. It is commercially supplied as a lyophilized powder intended to be solubilized in dilute aqueous hydrochloric acid immediately prior to administration. We have envisioned a "ready-to-use" glucagon as a drug of more immediate and likely use. Through a series of iterative changes in the native sequence we have identified glucagon analogs of appreciably enhanced aqueous solubility at physiological pH, and of chemical stability suitable for routine medicinal use. The superior biophysical properties were achieved in part through adjustment of the isoelectric point by use of a C-terminal Asp-Glu dipeptide. The native glutamines at positions 3, 20 and 24 as well as the methionine at 27 were substituted with amino acids of enhanced chemical stability, as directed by a full alanine scan of the native hormone. Of utmost additional importance was the dramatically enhanced stability of the peptide when Ser16 was substituted with alpha,aminoisobutyric acid (Aib), a substitution that stabilizes peptide secondary structure. The collective set of changes yield glucagon analogs of comparable in vitro and in vivo biological character to native hormone but with biophysical properties much more suitable for clinical use.

摘要

半个多世纪以来,胰高血糖素一直被用作治疗危及生命的低血糖的重要急救药物。它以冻干粉末的形式供应,旨在使用前在稀盐酸中溶解。我们设想了一种“即用型”胰高血糖素,它更即时,更可能被使用。通过对天然序列进行一系列的迭代改变,我们发现了一些胰高血糖素类似物,它们在生理 pH 值下具有明显增强的水溶性,并且具有适合常规药用的化学稳定性。通过使用 C 末端 Asp-Glu 二肽来调节等电点,部分实现了优越的生物物理性质。位置 3、20 和 24 的天然谷氨酰胺以及 27 位的蛋氨酸被增强化学稳定性的氨基酸取代,这是根据天然激素的全丙氨酸扫描来指导的。最重要的是,当 Ser16 被α-氨基异丁酸(Aib)取代时,肽的稳定性大大增强,这种取代稳定了肽的二级结构。这一系列的变化产生了与天然激素具有相当体外和体内生物学特征的胰高血糖素类似物,但具有更适合临床使用的生物物理性质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/3986664/5e696d6d1430/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/3986664/2593c62e5f8c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/3986664/e83ea0d35d3b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/3986664/c1620b4ac1e3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/3986664/694b79e3600e/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/3986664/76b57a747b73/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/3986664/77ccf5d8c458/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/3986664/e8960c813645/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/3986664/3a3a2390cd0f/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/3986664/5e696d6d1430/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/3986664/2593c62e5f8c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/3986664/e83ea0d35d3b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/3986664/c1620b4ac1e3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/3986664/694b79e3600e/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/3986664/76b57a747b73/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/3986664/77ccf5d8c458/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/3986664/e8960c813645/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/3986664/3a3a2390cd0f/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/3986664/5e696d6d1430/gr9.jpg

相似文献

1
A glucagon analog chemically stabilized for immediate treatment of life-threatening hypoglycemia.一种化学稳定的胰高血糖素类似物,可立即用于治疗危及生命的低血糖。
Mol Metab. 2014 Jan 22;3(3):293-300. doi: 10.1016/j.molmet.2014.01.006. eCollection 2014 Jun.
2
Optimization of the native glucagon sequence for medicinal purposes.用于医学目的的天然胰高血糖素序列的优化。
J Diabetes Sci Technol. 2010 Nov 1;4(6):1322-31. doi: 10.1177/193229681000400605.
3
Pyridyl-alanine as a Hydrophilic, Aromatic Element in Peptide Structural Optimization.吡啶基丙氨酸作为肽结构优化中的亲水性芳香族元素
J Med Chem. 2016 Sep 8;59(17):8061-7. doi: 10.1021/acs.jmedchem.6b00840. Epub 2016 Aug 25.
4
Native Design of Soluble, Aggregation-Resistant Bioactive Peptides: Chemical Evolution of Human Glucagon.可溶性、抗聚集生物活性肽的天然设计:人胰高血糖素的化学进化
ACS Chem Biol. 2016 Dec 16;11(12):3412-3420. doi: 10.1021/acschembio.6b00923. Epub 2016 Nov 8.
5
Enhanced protein thermostability by Ala-->Aib replacement.通过丙氨酸替换为α-氨基异丁酸提高蛋白质热稳定性。
Biochemistry. 1998 Feb 10;37(6):1686-96. doi: 10.1021/bi971937o.
6
Gcg-XTEN: an improved glucagon capable of preventing hypoglycemia without increasing baseline blood glucose.Gcg-XTEN:一种改良的胰高血糖素,能够在不增加基础血糖的情况下预防低血糖。
PLoS One. 2010 Apr 14;5(4):e10175. doi: 10.1371/journal.pone.0010175.
7
Metabolic stability, receptor binding, cAMP generation, insulin secretion and antihyperglycaemic activity of novel N-terminal Glu9-substituted analogues of glucagon-like peptide-1.胰高血糖素样肽-1新型N端Glu9取代类似物的代谢稳定性、受体结合、cAMP生成、胰岛素分泌及降血糖活性
Biol Chem. 2003 Dec;384(12):1543-51. doi: 10.1515/BC.2003.171.
8
Structural Refinement of Glucagon for Therapeutic Use.用于治疗用途的胰高血糖素的结构改造。
J Med Chem. 2020 Apr 9;63(7):3447-3460. doi: 10.1021/acs.jmedchem.9b01493. Epub 2019 Dec 18.
9
Effects of iodination on the distribution of peptide hormones in aqueous two-phase polymer systems.碘化作用对肽类激素在双水相聚合物系统中分布的影响。
Biochem J. 1974 Oct;143(1):83-91. doi: 10.1042/bj1430083.
10
Structure-function relationship studies of bovine parathyroid hormone [bPTH(1-34)] analogues containing alpha-amino-iso-butyric acid (Aib) residues.含α-氨基异丁酸(Aib)残基的牛甲状旁腺激素[bPTH(1-34)]类似物的结构-功能关系研究
Biopolymers. 2003 Mar;68(3):437-57. doi: 10.1002/bip.10294.

引用本文的文献

1
A Glucose-Responsive Glucagon-Micelle for the Prevention of Hypoglycemia.一种用于预防低血糖的葡萄糖响应性胰高血糖素胶束。
ACS Cent Sci. 2024 Oct 2;10(11):2036-2047. doi: 10.1021/acscentsci.4c00937. eCollection 2024 Nov 27.
2
Uniform trehalose nanogels for glucagon stabilization.用于胰高血糖素稳定化的均匀海藻糖纳米凝胶
RSC Appl Polym. 2024 Mar 13;2(3):473-482. doi: 10.1039/d3lp00226h. eCollection 2024 May 23.
3
Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potency.机器学习设计出具有增强生物学效力的新型 GCGR/GLP-1R 双重激动剂。

本文引用的文献

1
Optimization of the native glucagon sequence for medicinal purposes.用于医学目的的天然胰高血糖素序列的优化。
J Diabetes Sci Technol. 2010 Nov 1;4(6):1322-31. doi: 10.1177/193229681000400605.
2
Stability of synthetic exendin-4 in human plasma in vitro.
Protein Pept Lett. 2007;14(1):19-25. doi: 10.2174/092986607779117272.
3
Glucagon: the effects of its excess and deficiency on insulin action.胰高血糖素:其过量与缺乏对胰岛素作用的影响。
Nutr Metab Cardiovasc Dis. 2006 Mar;16 Suppl 1:S28-34. doi: 10.1016/j.numecd.2005.10.018. Epub 2006 Feb 9.
Nat Chem. 2024 Sep;16(9):1436-1444. doi: 10.1038/s41557-024-01532-x. Epub 2024 May 16.
4
Hormone Analogues with Unique Signaling Profiles from Replacement of α-Residue Triads with β/γ Diads.用β/γ 二联体替代α-残基三联体,获得具有独特信号特征的激素类似物。
J Am Chem Soc. 2023 Sep 20;145(37):20539-20550. doi: 10.1021/jacs.3c06703. Epub 2023 Sep 11.
5
Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors.计算肽设计同时靶向胰高血糖素和胰高血糖素样肽-1 受体。
J Chem Inf Model. 2023 Aug 14;63(15):4934-4947. doi: 10.1021/acs.jcim.3c00752. Epub 2023 Jul 31.
6
New Insights into the Structure and Function of Class B1 GPCRs.B1 类 G 蛋白偶联受体的结构与功能的新见解。
Endocr Rev. 2023 May 8;44(3):492-517. doi: 10.1210/endrev/bnac033.
7
Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone Peptide-Derived G Protein Coupled Receptor Agonists.心脏代谢疾病的新型治疗方法:激素肽衍生的 G 蛋白偶联受体激动剂研究中的最新发现。
Nutrients. 2022 Sep 13;14(18):3775. doi: 10.3390/nu14183775.
8
The Location of Missense Variants in the Human GIP Gene Is Indicative for Natural Selection.人类 GIP 基因中错义变异的位置表明其受到自然选择的影响。
Front Endocrinol (Lausanne). 2022 Jun 29;13:891586. doi: 10.3389/fendo.2022.891586. eCollection 2022.
9
Mutational Landscape of the Proglucagon-Derived Peptides.前胰高血糖素衍生肽的突变景观。
Front Endocrinol (Lausanne). 2021 Jun 17;12:698511. doi: 10.3389/fendo.2021.698511. eCollection 2021.
10
Structurally Based Design of Glucagon Mutants That Inhibit Fibril Formation.基于结构的胰高血糖素突变体设计,抑制纤维形成。
Biochemistry. 2021 Jun 29;60(25):2033-2043. doi: 10.1021/acs.biochem.1c00214. Epub 2021 Jun 14.
4
Studies on the mechanism of aspartic acid cleavage and glutamine deamidation in the acidic degradation of glucagon.胰高血糖素酸性降解过程中天冬氨酸裂解和谷氨酰胺脱酰胺机制的研究。
J Pharm Sci. 2005 Sep;94(9):1912-27. doi: 10.1002/jps.20405.
5
Mishandling of the therapeutic peptide glucagon generates cytotoxic amyloidogenic fibrils.治疗性肽胰高血糖素处理不当会产生具有细胞毒性的淀粉样原纤维。
Pharm Res. 2004 Jul;21(7):1274-83. doi: 10.1023/b:pham.0000033016.36825.2c.
6
The estimation of glutaminyl deamidation and aspartyl cleavage rates in glucagon.胰高血糖素中谷氨酰胺脱酰胺和天冬氨酸裂解速率的估算。
Int J Pharm. 2004 Apr 1;273(1-2):213-9. doi: 10.1016/j.ijpharm.2004.01.006.
7
Prevention of peptide fibril formation in an aqueous environment by mutation of a single residue to Aib.通过将单个残基突变为Aib在水性环境中预防肽原纤维形成。
Biochemistry. 2003 Apr 22;42(15):4492-8. doi: 10.1021/bi026856t.
8
Exendin-4 and glucagon-like-peptide-1: NMR structural comparisons in the solution and micelle-associated states.艾塞那肽-4与胰高血糖素样肽-1:溶液态和胶束结合态的核磁共振结构比较
Biochemistry. 2001 Nov 6;40(44):13188-200. doi: 10.1021/bi010902s.
9
The degradation pathways of glucagon in acidic solutions.胰高血糖素在酸性溶液中的降解途径。
Int J Pharm. 2000 Aug 10;203(1-2):115-25. doi: 10.1016/s0378-5173(00)00438-5.
10
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.糖尿病强化治疗对胰岛素依赖型糖尿病长期并发症发生及进展的影响。
N Engl J Med. 1993 Sep 30;329(14):977-86. doi: 10.1056/NEJM199309303291401.